NCT07673367
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
Clinical trial condition
Explore clinical trials studying Refractory Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.
NCT07673367
NCT06675123
NCT07003295
NCT06839053
NCT06859008
NCT05249959
NCT04484012
NCT05910801
NCT07578077